Article Text

Download PDFPDF
Original article
Prevalence and sociodemographic correlates of cervicovaginal human papillomavirus (HPV) carriage in a cross-sectional, multiethnic, community-based female Asian population
  1. Su Pei Khoo1,
  2. Nirmala Bhoo-Pathy1,
  3. Siew Hwei Yap1,
  4. Mohd Khairul Anwar Shafii1,
  5. Nazrilla Hairizan Nasir2,
  6. Jerome Belinson3,
  7. ShriDevi Subramaniam4,
  8. Pik Pin Goh4,
  9. Ming Zeng5,
  10. Hong Dong Tan5,6,
  11. Patti Gravitt7,
  12. Yin Ling Woo1
  1. 1 Faculty of Medicine, University of Malaya, Kuala Lumpur, Wilayah Persekutuan, Malaysia
  2. 2 Division of Family Health Development, Ministry of Health, Kuala Lumpur, Wilayah Persekutuan, Malaysia
  3. 3 Preventive Oncology International Inc and the Cleveland Clinic, Cleveland, Ohio, USA
  4. 4 National Clinical Research Centre, Ministry of Health, Kuala Lumpur, Wilayah Persekutuan, Malaysia
  5. 5 Beijing Genome, Shenzhen, China
  6. 6 Complete Genomics, San Jose, California, USA
  7. 7 Milken Institute of Public Health, George Washington University, Washington, District of Columbia, USA
  1. Correspondence to Dr Yin Ling Woo, Faculty of Medicine, University of Malaya, Kuala Lumpur, Wilayah Persekutuan, 50603, Malaysia; ylwoo{at}ummc.edu.my

Footnotes

  • Handling editor Jackie A Cassell

  • Contributors YLW, PG, NHN, NB-P and JB conceptualised the study. YLW, PG, PPG, NHN, NB-P and JB contributed to human resources and execution of the study. SPK, SHY, MKAS, NHN and SS recruited the volunteers. SPK, PG and YLW wrote the manuscript. JB, MZ and HDT contributed to HPV DNA testing. All authors reviewed and revised the manuscript before submission.

  • Funding This study was supported by University Malaya High Impact Research Grant (grant no: UM.C/625/1/HIR/MOHE/MED/12), University Malaya Research Grant (RP029-14HTM), National Clinical Research Centre of the Ministry of Health of Malaysia, Beijing Genome Institute, Preventive Oncology International, and an investigator-initiated study grant by Merck Sharp and Dohme (Malaysia).

  • Competing interests None declared.

  • Ethics approval The study received approval from the Medical Research Ethics Committee (NMRR-13-444-14609) and the University of Malaya Medical Ethics Committee (MREC989.32).

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Handling editor Jackie A Cassell

  • Contributors YLW, PG, NHN, NB-P and JB conceptualised the study. YLW, PG, PPG, NHN, NB-P and JB contributed to human resources and execution of the study. SPK, SHY, MKAS, NHN and SS recruited the volunteers. SPK, PG and YLW wrote the manuscript. JB, MZ and HDT contributed to HPV DNA testing. All authors reviewed and revised the manuscript before submission.

  • Funding This study was supported by University Malaya High Impact Research Grant (grant no: UM.C/625/1/HIR/MOHE/MED/12), University Malaya Research Grant (RP029-14HTM), National Clinical Research Centre of the Ministry of Health of Malaysia, Beijing Genome Institute, Preventive Oncology International, and an investigator-initiated study grant by Merck Sharp and Dohme (Malaysia).

  • Competing interests None declared.

  • Ethics approval The study received approval from the Medical Research Ethics Committee (NMRR-13-444-14609) and the University of Malaya Medical Ethics Committee (MREC989.32).

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.